Staburo team home office workout

Staburo team home office workout

Staburo team stays healthy, positive and at home

The Staburo team is entirely working from home, which works quite seamlessly thanks to a well prepared IT infrastructure and software tools.

To keep a positive attitude during uncertain times, Staburo Managing Director Roland Stieger decided to offer short morning workouts via MS Teams to start the home office day fresh, until the situation (especially in our neighboring countries) hopefully eases.

We are very proud to support the pharmaceutical industry with our services, which is the only industry that can build sustainable weapons against infectious diseases.

Data analysis, clinical biostatistics and more.

Students from the University of Copenhagen visited Staburo

Students from the University of Copenhagen visited Staburo

Students from the University of Copenhagen visited Staburo

Nine Master students from the University of Copenhagen visited Staburo as part of their Statistical Study Trip to Munich.

After a welcome from our Managing Director Josef Höfler, the students learned more about how statistics is applied in the “real world”. Many topics were covered, including biostatistics, programming, consulting and precision medicine. After an office tour and a short overview on potential Master and PhD theses, the students discussed with our employees about what it is like to work as a statistician in a company.

We had a great time presenting the various exciting areas of work at Staburo. If you are also interested in our expertise, do not hesitate to contact us.

Data analysis, clinical biostatistics and more.

Training @ Staburo: AMNOG and HTA

Training @ Staburo: AMNOG and HTA

Training @ Staburo: AMNOG and HTA

How beneficial are new drugs? This question gained more and more importance, after the German authorities introduced the AMNOG law in 2011, to restructure the market and the reimbursement system. Since then, it is obligatory that every new introduced medication runs through the process of an early benefit assessment, where at the end a decision is made, if there is a beneficial need for the new introduced drug. Based on this benefit, the market price of the product is negotiated.

The training was structured in two major parts. In the beginning, the whole process was shown with the major players in the process (like the G-BA and IQWiG) and the process of the early benefit assessment itself. Here, the relevant statistics topics where highlighted. Furthermore, the whole process was presented.

The second part was about the statistics workflow needed for analyses in module 4 of the dossier. Here, the mandatory endpoints, like survival and quality of life, where shown in combination with the analysis to perform to proof the benefit of the new drug. In addition to the analysis of the mandatory and supportive analysis, a short overview of the work package in statistics was presented, beginning with the planning of the confirmatory trial and the tasks during the whole process, until the decision about the benefit is made.

In the end of the presentation, recent decisions of the G-BA and the IQWiG were shown, also to highlight potential problems, which can occur during the process.

Data analysis, clinical biostatistics and more.

Mitarbeiter Angebotsmanagement/Controlling/Rechnungsmanagement (m/w/d)

Mitarbeiter Angebotsmanagement/Controlling/Rechnungsmanagement (m/w/d)

Die Staburo GmbH ist ein Münchner Biostatistikunternehmen, das auf statistische Beratung und Programmierung im Umfeld von klinischen Studien spezialisiert ist. Aufbauend auf unseren 6 Säulen (Klinische Statistik, Translationale Medizin & Biomarker, Pharmakokinetik/-dynamik, Nutzenbewertung, Nichtklinische Statistik und Statistische Programmierung mit CDISC) erarbeiten wir in Projektteams maßgeschneiderte Lösungen.
Unsere Kunden sind renommierte Pharmafirmen (7 der Top 20), CROs und Biotechunternehmen, mit denen wir flexibel und gerne auch vor Ort zusammenarbeiten.

Zur Erweiterung unseres Teams suchen wir zum nächstmöglichen Zeitpunkt zur Festanstellung einen

Mitarbeiter Angebotsmanagement/Controlling/
Rechnungsmanagement (m/w/d)

in Vollzeit oder Teilzeit

Ihre Aufgabengebiete:
  • Sie erstellen maßgeschneiderte Angebote für unsere Kunden
  • Sie unterstützen uns bei Controllingaufgaben (z.B. Finanzen, Zeiterfassung)
  • Sie erstellen Rechnungen und prüfen den Rechnungseingang
Ihr Profil:
  • Erfolgreich abgeschlossenes Studium (z.B. BWL, Statistik, Life Sciences) oder abgeschlossene Kaufmännische Ausbildung, Arbeitserfahrung im Bereich Pharma und Kenntnisse in BWL sind ein Vorteil
  • Sie legen sehr viel Wert auf Präzision und Genauigkeit
  • Sie verfügen über gute EDV-Kenntnisse, besonders in Excel
  • Sie kommunizieren sicher auf Englisch
  • Teamfähigkeit und ein hohes Maß an Eigeninitiative sind Ihnen wichtig
Was wir Ihnen bieten:

Es erwartet Sie eine abwechslungsreiche und eigenverantwortliche Tätigkeit. Wir legen großen Wert auf Kommunikation, flache Hierarchien, offene Unternehmenskultur und ein harmonisches Arbeitsumfeld. Unser Standort in München bietet sehr gute Arbeitsbedingungen, moderne Büroräume und eine schnelle Anbindung an den öffentlichen Nahverkehr.

Neugierig geworden?

Dann informieren Sie sich auf unserer Internetseite: www.staburo.de und werden Sie Teil unseres stetig wachsenden Teams!
Wir freuen uns über Ihre vollständigen Bewerbungsunterlagen mit Angabe Ihrer Gehaltsvorstellung. Für eine schnelle Abwicklung des Bewerbungsprozesses bitten wir um eine E-Mail-Bewerbung an: bewerbung@staburo.de
Wir freuen uns, Sie bald kennenzulernen!

Hier finden Sie diese Stellenanzeige als PDF Datei.

 

Staburo at the G-BA in Berlin

Staburo at the G-BA in Berlin

Staburo at the G-BA in Berlin

Josef Höfler from Staburo participated as statistical expert in an advisory meeting at the institution of “Gemeinsamer Bundesausschuss” in Berlin, in the context of health technology assessment.

The Federal Joint Committee (G-BA) is the highest decision-making body of the joint self-government of physicians, dentists, hospitals and health insurance funds in Germany.

It issues directives for the benefit catalogue of the statutory health insurance funds (GKV) for more than 73 million insured persons and thus specifies which services in medical care are reimbursed by the GKV.

Data analysis, clinical biostatistics and more.